- $0.00m
- -$1.31m
- $5.20m
- 25
- 100
- 30
- 51
Annual cashflow statement for OpGen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26.2 | -34.8 | -37.3 | -32.7 | 12 |
| Depreciation | |||||
| Non-Cash Items | 2.21 | 12.7 | 17.1 | 18.1 | -12.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.73 | -2.05 | -1.95 | -1.03 | -4.14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -23.4 | -21.5 | -20.4 | -14.3 | -4.87 |
| Capital Expenditures | -0.13 | -1.98 | -0.591 | -0.8 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.933 | — | — | — | — |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.06 | -1.98 | -0.591 | -0.8 | 0 |
| Financing Cash Flow Items | — | — | — | — | 0.09 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 34.1 | 47.5 | -6.74 | 8.37 | 5.03 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.2 | 22.5 | -28.7 | -6.48 | 0.159 |